VALSTEP S 100

MRP

630/Strip

Description

• Sacubitril 49 mg + Valsartan 51 mg

Doses

• As directed by the physician.

Indication

• Sacubitril/valsartan is the first agent to be approved in a new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). The medication is FDA-approved to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) with NYHA class II, III, or IV.